The results of our experiments are in agreement with this hypothesis: synergistic suppression of various BRAF- and RAS-mutant CRC cell lines was achieved by various combinations of MEK and IMPDH inhibitors. The gene discussed is BRAF; the disease is colorectal carcinoma.